key: cord-0699151-h744xez6
authors: Ish, Somya; Ish, Pranav
title: Facial nerve palsy after COVID-19 vaccination – A rare association or a coincidence
date: 2021-09-03
journal: Indian J Ophthalmol
DOI: 10.4103/ijo.ijo_1658_21
sha: 906a9b3f75b2aa5fdf0abc1e4f31e7a81892fda7
doc_id: 699151
cord_uid: h744xez6

nan

Dear Editor, A 50-year old male presented with difficulty in closing the right eye associated with redness and watering for 3 days. There was no history of diabetes, hypertension, or any other systemic disease. On past history, the patient had received the first dose of COVAXIN vaccine on April 3, 2021 and the second dose on May 11, 2021. On examination, his best-corrected vision was 20/20 in both eyes. Lagophthalmos with lower lid ectropion temporally was present. There was loss of forehead wrinkling, naso-labial fold, and drooping of angle of mouth of the right side, suggestive of right-sided lower motor neuron facial nerve palsy [ Fig. 1 ]. On anterior segment examination of the right eye, there was conjunctival congestion, cornea was clear, and rest was normal. Anterior segment examination of the left eye was normal. Fundus examination of both eyes was normal. A referral was sent to otolaryngologist. The ear examination was reported as normal external ear, normal tympanic membrane with no hearing loss.

The patient was prescribed topical antibiotics for eyes with frequent use of lubricating drops. Taping of the right eye was advised when sleeping. The patient was also started on oral prednisolone at 1 mg/kg for 2 weeks. The patient showed response from 1 week of therapy. At review on 10 th day, the lagophthalmos decreased, lower lid ectropion improved, no conjunctival congestion was present, and facial asymmetry had also improved [ Fig. 2 ].

COVID-19 vaccines during trials have documented facial nerve palsy in vaccine recipients. Four vaccine recipients of Pfizer-BioNTech© [1] and three of Moderna© vaccine [2] have developed Bell's palsy which were labeled as medically attended adverse event. Following this, the United States Food and Drug Administration and the Centers for Disease Control and Prevention had recommended to keep a strict vigil for such symptoms post COVID-19 vaccination as similar cases have been previously reported with influenza vaccine also. [3] [4] [5] The timing of the palsy ranged from the first dose to around 1 month after the second dose (median time of 2 days with range from 0 to 79 days after the first dose). Our patient developed right-sided facial nerve palsy 3 weeks after the second dose (7 weeks after the first dose) of COVAXIN© vaccine. After the global release of vaccines, there have been rare reports of similar cases. A 57-year-old patient in the United Letters to the Editor States of America developed bell's palsy 36 h after the second dose of Pfizer-BioNTech© vaccine. However, it was the fourth event of facial nerve palsy in the patient as she had underlying Melkersson-Rosenthal Syndrome. [3] Another case reported developed facial nerve palsy within a week of vaccination with Pfizer-BioNTech© vaccine. [6] Autoimmune mechanisms with interferons activation following vaccine have been suggested as the possible mechanism, but there is no evidence yet. [7] E ve n t h o u g h , r a r e a d ve r s e e ve n t s f o l l o w i n g immunization (AEFI) should not be a deterrent for COVID-19 vaccination and all attempts should be made to decrease hesitancy [8] among the people for vaccination; however, a strict vigil and regular documentation should always be done for all AEFI to ensure safety. [9] To conclude, temporal association, viral vaccines, history of reports with influenza vaccine, and biological plausibility suggest that facial nerve palsy post COVID-19 vaccination can be an adverse event, but in view of lack of evidence and rare incidence, the association may be a mere coincidence. However, in view of response with steroids, a high index of suspicion can be maintained for early diagnosis and appropriate treatment.

Written informed consent of the patient for sharing his clinical details and photographs was taken.

Nil. 

Vaccines and Related Biological Products Advisory Committee Meeting-FDA Briefing Document

Vaccines and Related Biological Products Advisory Committee Meeting

Bell's palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell's palsy

Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States

A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: Reports to the Vaccine adverse event reporting system (VAERS)-United States

Bell's palsy following COVID-19 vaccination

Bell's palsy and SARS-CoV-2 vaccines-an unfolding story

BAME community hesitancy in the UK for COVID-19 vaccine: Suggested solutions

Safdarjung Covid-Vaccination Group. The initial experience of COVID-19 vaccination from a Tertiary care centre of India. Monaldi Arch Chest Dis

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.